Novo Nordisk’s Wegovy reduces risk of adverse cardiovascular events by 20% in obese adults
August 08, 2023 at 07:29 AM EDT
Obesity drug shows positive results in tackling some of the other illnesses caused by being overweight.
Photography by Christophe Tomatis